Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

• Published in: Ophthalmology retina Vol. 8; no. 4; p. 350
• Main Authors: Izquierdo-Serra, Jordi, Martin-Pinardel, Ruben, Moll-Udina, Aina, Bernal-Morales, Carolina, Garay-Aramburu, Gonzaga, Sanchez-Monroy, Jorge, Arruabarrena, Carolina, Fernandez-Hortelano, Ana, Figueroa, Marta S, Abraldes, Maximino, Lavid de Los Mozos, Francisco Javier, Zapata, Miguel Angel, Ruiz-Moreno, Jose Maria, Broc-Iturralde, Laura, Gonzalez-Guijarro, Jacobo, Escobar-Barranco, Jose Juan, Gallego-Pinazo, Roberto, Parrado-Carrillo, Alba, Dotti-Boada, Marina, Alforja, Socorro, Figueras-Roca, Marc, Barthelmes, Daniel, Gillies, Mark C, Casaroli-Marano, Ricardo P, Zarranz-Ventura, Javier
• Format: Journal Article
• Language: English
• Published: United States 01.04.2024
• Subjects: Angiogenesis Inhibitors; Humans; Intravitreal Injections; Macular Degeneration - drug therapy; Neovascularization, Pathologic; Retrospective Studies; Vascular Endothelial Growth Factor A; Benchmark standard; Audit; Age-related macular degeneration; Subtype; Outcome

To evaluate the influence of macular neovascularization (MNV) lesion type on 12-month clinical outcomes in treatment-naive eyes with neovascular age-related macular degeneration (nAMD) treated with anti-VEGF drugs nationwide. Multicenter national nAMD database observational study. One thousand six h...